-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – HTD-1801 in Hypertriglyceridemia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - HTD-1801 in Hypertriglyceridemia report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. HTD-1801 in Hypertriglyceridemia Drug Details: HTD-1801 (berberine ursodeoxycholate) is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Histamine Dihydrochloride in Chronic Traumatic Encephalopathy (CTE)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Histamine Dihydrochloride in Chronic Traumatic Encephalopathy (CTE) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Histamine Dihydrochloride in Chronic Traumatic Encephalopathy (CTE) Drug Details:...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Tenalisib in Marginal Zone B-cell Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Tenalisib in Marginal Zone B-cell Lymphoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Tenalisib in Marginal Zone B-cell Lymphoma Drug Details: Tenalisib (RP-6530)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Tenalisib in Follicular Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Tenalisib in Follicular Lymphoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Tenalisib in Follicular Lymphoma Drug Details: Tenalisib (RP-6530) is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Levonadifloxacin in Methicillin-Resistant Staphylococcus aureus (MRSA) Infections
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Levonadifloxacin in Methicillin-Resistant Staphylococcus aureus (MRSA) Infections report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Levonadifloxacin in Methicillin-Resistant Staphylococcus aureus (MRSA) Infections Drug Details:...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Levonadifloxacin in Gram-Negative Bacterial Infections
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Levonadifloxacin in Gram-Negative Bacterial Infections report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Levonadifloxacin in Gram-Negative Bacterial Infections Drug Details: Levonadifloxacin (Emrok) is a...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Tenalisib in Metastatic Breast Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Tenalisib in Metastatic Breast Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Tenalisib in Metastatic Breast Cancer Drug Details: Tenalisib (RP-6530) is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Defibrotide Sodium in Beta Thalassaemia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Defibrotide Sodium in Beta Thalassaemia report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Defibrotide Sodium in Beta Thalassaemia Drug Details: Defibrotide sodium (Noravid, Defitelio,...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Defibrotide Sodium in Sickle Cell Disease
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Defibrotide Sodium in Sickle Cell Disease report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Defibrotide Sodium in Sickle Cell Disease Drug Details: Defibrotide...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Defibrotide Sodium in Mucocutaneous Lymph Node Syndrome (Kawasaki Disease)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Defibrotide Sodium in Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Defibrotide Sodium in Mucocutaneous Lymph Node...